AYTU
Aytu BioScience Inc
NASDAQ: AYTU · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.58
+2.38% today
Updated 2026-04-30
Market cap
$27.05M
P/E ratio
—
P/S ratio
0.43x
EPS (TTM)
$-3.44
Dividend yield
—
52W range
$1 – $3
Volume
0.0M
Aytu BioScience Inc (AYTU) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+11.2%
Last 4 quarters
Revenue YoY growth
-6.5%
Most recent quarter
EPS YoY growth
-279.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-9.3%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-17.3%
2025-09-23
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-04 | $-0.23 | +52.9% | $2.62 | $2.30 | -12.2% |
| 2025-11-13 | $-0.08 | +59.0% | $2.06 | $2.09 | +1.5% |
| 2025-09-23 | $-2.93 | -652.8% | $2.49 | $2.06 | -17.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.50 | $-0.23 | +52.9% | $15.16M | -6.5% |
| 2025-09-30 | $-0.20 | $-0.08 | +59.0% | $13.89M | -16.2% |
| 2025-06-30 | $0.53 | $-2.93 | -652.8% | $15.13M | -15.8% |
| 2025-03-31 | $-0.64 | $0.21 | +132.8% | $18.45M | +31.6% |
| 2024-12-31 | $-0.28 | $0.13 | +146.4% | $16.22M | -13.5% |
| 2024-09-30 | $-0.34 | $-0.15 | +55.9% | $16.57M | -7.0% |
| 2024-06-30 | $-0.45 | $-0.82 | -82.2% | $17.98M | -41.5% |
| 2024-03-31 | $-0.64 | $-0.52 | +18.8% | $14.03M | -38.3% |
| 2023-12-31 | $-0.25 | $-0.04 | +84.0% | $18.75M | — |
| 2023-09-30 | $-0.04 | $-1.48 | -3600.0% | $17.82M | — |
| 2023-06-30 | $-0.95 | $-0.59 | +37.9% | $30.73M | — |
| 2023-03-31 | $-0.63 | $-1.93 | -206.3% | $22.73M | — |
Frequently asked questions
Has Aytu BioScience Inc beaten earnings estimates?
Aytu BioScience Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +11.2% over the last 4 quarters.
How does AYTU stock react to earnings?
AYTU stock has moved an average of -9.3% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Aytu BioScience Inc's revenue growth rate?
Aytu BioScience Inc reported year-over-year revenue growth of -6.5% in its most recent quarter, with EPS growing -279.4% year-over-year.